Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06639295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

StatusActive, Not Recruiting
PhasePhase 3
Started2024-11-22
View on ClinicalTrials.gov ↗

Amendment history

2025-11-25
notable
Not Yet Recruiting→Active, Not Recruiting Study Identification, Study Status, Oversight, Study Design, Contacts/Locations v1
Trial statusNot Yet Recruiting→Active, Not Recruiting
Start dateestimated 2024-11→confirmed 2024-11-22
Enrollment targetestimated 240→confirmed 243
Study sitescontacts updated at 1 of 1 site
Study titlerevised
A Study to Evaluate 611 in Patients withWith Chronic Rhinosinusitis withWith Nasal Polyps
2024-10-10
minor
Original filing
This study will evaluate the effect and safety of 611 in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Trial Details
NCT Number NCT06639295
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Sinusitis, Nasal Polyps
Enrollment 243 participants
Start Date 2024-11-22
Primary Completion 2025-12 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-03